Niemira, M.; Borowa-Mazgaj, B.; Bader, S.B.; Moszyńska, A.; Ratajewski, M.; Karaś, K.; Kwaśniewski, M.; Krętowski, A.; Mazerska, Z.; Hammond, E.M.;
et al. Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. Biomedicines 2020, 8, 292.
https://doi.org/10.3390/biomedicines8090292
AMA Style
Niemira M, Borowa-Mazgaj B, Bader SB, Moszyńska A, Ratajewski M, Karaś K, Kwaśniewski M, Krętowski A, Mazerska Z, Hammond EM,
et al. Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. Biomedicines. 2020; 8(9):292.
https://doi.org/10.3390/biomedicines8090292
Chicago/Turabian Style
Niemira, Magdalena, Barbara Borowa-Mazgaj, Samuel B. Bader, Adrianna Moszyńska, Marcin Ratajewski, Kaja Karaś, Mirosław Kwaśniewski, Adam Krętowski, Zofia Mazerska, Ester M. Hammond,
and et al. 2020. "Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells" Biomedicines 8, no. 9: 292.
https://doi.org/10.3390/biomedicines8090292
APA Style
Niemira, M., Borowa-Mazgaj, B., Bader, S. B., Moszyńska, A., Ratajewski, M., Karaś, K., Kwaśniewski, M., Krętowski, A., Mazerska, Z., Hammond, E. M., & Skwarska, A.
(2020). Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells. Biomedicines, 8(9), 292.
https://doi.org/10.3390/biomedicines8090292